Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 May 25:2022:6584631.
doi: 10.1155/2022/6584631. eCollection 2022.

Application of Adsorptive Blood Purification Techniques during Cardiopulmonary Bypass in Cardiac Surgery

Affiliations
Review

Application of Adsorptive Blood Purification Techniques during Cardiopulmonary Bypass in Cardiac Surgery

Meng-Han Liu et al. Oxid Med Cell Longev. .

Abstract

By reason of surgical demand, the majority of cardiovascular procedures still depend on the use of cardiopulmonary bypass (CPB). Due to the nonphysiological state of CPB, it can cause complex and unpredictable inflammatory response, which may lead to significant morbidity and mortality. Unfortunately, the pharmacological and mechanical strategies that currently exist do not offer significant advantages in controlling inflammatory response and improving patient outcomes. The best strategy to reduce inflammation in CPB is still uncertain. In recent years, adsorptive blood purification techniques (BPTs) have emerged, among which CytoSorb is the latest representative device. Currently, the primary application area of adsorptive BPTs is in the control and treatment of systemic hyperinflammatory states, such as refractory septic shock patients. However, the evidences on efficacy and safety of adsorptive BPTs application during CPB surgery are still inconclusive, so we summarize the relevant evidences here and suggest future potential research areas.

PubMed Disclaimer

Conflict of interest statement

The authors declare that there is no conflict of interest regarding the publication of this paper.

References

    1. Larmann J., Theilmeier G. Inflammatory response to cardiac surgery: cardiopulmonary bypass versus non- cardiopulmonary bypass surgery. Best Practice & Research Clinical Anaesthesiology . 2004;18(3):425–438. doi: 10.1016/j.bpa.2003.12.004. - DOI - PubMed
    1. Farag M., Patil N. P., Sabashnikov A., et al. Comparison of two miniaturized cardiopulmonary bypass systems regarding inflammatory response. Artificial Organs . 2017;41(2):139–145. doi: 10.1111/aor.12750. - DOI - PubMed
    1. Durandy Y. Minimizing systemic inflammation during cardiopulmonary bypass in the pediatric population. Artificial Organs . 2014;38(1):11–18. doi: 10.1111/aor.12195. - DOI - PubMed
    1. Evora P., Tenorio D. F., Braile D. M. Is the cardiopulmonary bypass systemic inflammatory response overestimated? Brazilian Journal of Cardiovascular Surgery . 2018;33(4):I–III. doi: 10.21470/1678-9741-2018-0605. - DOI - PMC - PubMed
    1. Landis R. C., Brown J. R., Fitzgerald D., et al. Attenuating the systemic inflammatory response to adult cardiopulmonary bypass: a critical review of the evidence base. The Journal of Extra-Corporeal Technology . 2014;46(3):197–211. - PMC - PubMed